Details for Patent: 10,286,036
✉ Email this page to a colleague
Which drugs does patent 10,286,036 protect, and when does it expire?
Patent 10,286,036 protects LUPKYNIS and is included in one NDA.
This patent has thirty patent family members in twenty-three countries.
Summary for Patent: 10,286,036
| Title: | Protocol for treatment of lupus nephritis |
| Abstract: | By employing a pharmacodynamic dosing regimen, the effectiveness of a protocol for treatment of lupus nephritis with voclosporin can be maximized while minimizing undesirable side effects. |
| Inventor(s): | Solomons; Neil (Victoria, CA), Huizinga; Robert B. (North Saanich, CA) |
| Assignee: | AURINIA PHARMACEUTICALS INC. (Victoria, CA) |
| Application Number: | 15/835,219 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 10,286,036
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurinia | LUPKYNIS | voclosporin | CAPSULE;ORAL | 213716-001 | Jan 22, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF PATIENTS WITH ACTIVE LUPUS NEPHRITIS | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,286,036
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2018266850 | ⤷ Sign Up | |||
| Australia | 2024202977 | ⤷ Sign Up | |||
| Brazil | 112019023766 | ⤷ Sign Up | |||
| Canada | 3063040 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
